ICON SG&A Expenses 2010-2025 | ICLR

ICON annual/quarterly sg&a expenses history and growth rate from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • ICON sg&a expenses for the quarter ending March 31, 2025 were $0.198B, a 11.86% increase year-over-year.
  • ICON sg&a expenses for the twelve months ending March 31, 2025 were $0.749B, a 0.47% increase year-over-year.
  • ICON annual sg&a expenses for 2024 were $0.728B, a 5.23% decline from 2023.
  • ICON annual sg&a expenses for 2023 were $0.769B, a 1.31% decline from 2022.
  • ICON annual sg&a expenses for 2022 were $0.779B, a 33.05% increase from 2021.
ICON Annual SG&A Expenses
(Millions of US $)
2024 $728
2023 $769
2022 $779
2021 $585
2020 $342
2019 $337
2018 $326
2017 $324
2016 $326
2015 $327
2014 $336
2013 $314
2012 $281
2011 $256
2010 $233
2009 $231
ICON Quarterly SG&A Expenses
(Millions of US $)
2025-03-31 $198
2024-12-31 $151
2024-09-30 $205
2024-06-30 $194
2024-03-31 $177
2023-12-31 $196
2023-09-30 $185
2023-06-30 $188
2023-03-31 $200
2022-12-31 $227
2022-09-30 $167
2022-06-30 $190
2022-03-31 $195
2021-12-31 $203
2021-09-30 $207
2021-06-30 $90
2021-03-31 $86
2020-12-31 $89
2020-09-30 $83
2020-06-30 $83
2020-03-31 $87
2019-12-31 $86
2019-09-30 $85
2019-06-30 $83
2019-03-31 $82
2018-12-31 $83
2018-09-30 $81
2018-06-30 $81
2018-03-31 $81
2017-12-31 $82
2017-09-30 $79
2017-06-30 $81
2017-03-31 $81
2016-12-31 $84
2016-09-30 $81
2016-06-30 $80
2016-03-31 $81
2015-12-31 $83
2015-09-30 $82
2015-06-30 $81
2015-03-31 $80
2014-12-31 $94
2014-09-30 $84
2014-06-30 $88
2014-03-31 $79
2013-12-31 $88
2013-09-30 $81
2013-06-30 $78
2013-03-31 $76
2012-12-31 $79
2012-09-30 $71
2012-06-30 $69
2012-03-31 $68
2011-12-31 $67
2011-09-30 $72
2011-06-30 $57
2011-03-31 $60
2010-12-31 $-29
2010-09-30 $60
2010-06-30 $59
2010-03-31 $143
2009-12-31 $57
2009-09-30 $54
2009-06-30 $58
2009-03-31 $61
Sector Industry Market Cap Revenue
Medical Medical Services $14.957B $8.282B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $148.115B 27.47
CVS Health (CVS) United States $75.901B 9.43
Elevance Health (ELV) United States $65.016B 8.74
Cencora (COR) United States $56.164B 19.54
DiDi Global (DIDIY) China $25.650B 27.25
Labcorp Holdings (LH) United States $21.906B 17.29
Natera (NTRA) United States $18.548B 0.00
BioMerieux (BMXMF) France $17.068B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $15.156B 0.00
CochLear (CHEOY) Australia $13.609B 0.00
Solventum (SOLV) United States $12.725B 13.47
Medpace Holdings (MEDP) United States $12.583B 33.30
Revvity (RVTY) United States $11.135B 19.32
Viatris (VTRS) United States $10.786B 3.71
Avantor (AVTR) United States $9.547B 13.87
Sonic Healthcare (SKHHY) Australia $9.074B 0.00
Charles River Laboratories (CRL) United States $8.765B 17.17
HealthEquity (HQY) United States $8.282B 36.28
Caris Life Sciences,�Inc (CAI) United States $7.001B 0.00
Bausch + Lomb (BLCO) Canada $5.183B 30.52
Amplifon S.p.A (AMFPF) Italy $5.058B 27.69
BrightSpring Health Services (BTSG) United States $3.534B 32.42
Sotera Health (SHC) United States $3.446B 19.58
Surgery Partners (SGRY) United States $2.862B 37.22
Organon (OGN) United States $2.636B 2.80
GeneDx Holdings (WGS) United States $2.619B 60.38
Concentras Parent (CON) United States $2.589B 14.96
Alignment Healthcare (ALHC) United States $2.331B 0.00
Progyny (PGNY) United States $1.957B 43.08
PACS (PACS) United States $1.757B 0.00
Premier (PINC) United States $1.749B 13.27
GoodRx Holdings (GDRX) United States $1.739B 34.79
Ardent Health (ARDT) United States $1.532B 6.53
Teladoc Health (TDOC) United States $1.321B 0.00
Establishment Labs Holdings (ESTA) $1.192B 0.00
Pediatrix Medical (MD) United States $1.088B 8.28
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
QDM (QDMI) Hong Kong, SAR China $0.875B 300.00
Agilon Health (AGL) United States $0.799B 0.00
AMN Healthcare Services Inc (AMN) United States $0.740B 6.93
CareDx (CDNA) United States $0.708B 11.06
Embecta (EMBC) United States $0.628B 4.23
So-Young (SY) China $0.507B 0.00
InnovAge Holding (INNV) United States $0.489B 0.00
Nutex Health (NUTX) United States $0.474B 7.18
Sonida Senior Living (SNDA) United States $0.469B 0.00
Omada Health (OMDA) $0.468B 0.00
LifeMD (LFMD) United States $0.464B 0.00
Auna S.A (AUNA) Luxembourg $0.456B 10.27
SBC Medicals (SBC) United States $0.454B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.401B 0.00
Enhabit (EHAB) United States $0.337B 27.75
Oncology Institute (TOI) United States $0.323B 0.00
Performant Healthcare (PHLT) United States $0.276B 0.00
Beauty Health (SKIN) United States $0.213B 0.00
DocGo (DCGO) United States $0.145B 23.67
Sera Prognostics (SERA) United States $0.109B 0.00
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
KindlyMD (NAKA) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.061B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Biodesix (BDSX) United States $0.057B 0.00
ModivCare (MODV) United States $0.043B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.042B 0.00
Basel Medical Group (BMGL) Singapore $0.040B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Pheton Holdings (PTHL) China $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00